sfnp-2025-desktop
sfnp-2025-mobile

Transthyretin Amyloidosis (ATTR)

Société Francophone du Nerf Périphérique (SFNP) 2025

Congress Details

calanderJanuary 31 - February 1, 2025

locationParis, France

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Image
Oral

Congress Materials

Image
icon Presentation Type
Presentation
Image
location icon Location
Paris, France
Image
icon Title
HELIOS-A: 18-month randomised treatment extension analysis of vutrisiran in patients with hereditary transthyretin amyloidosis with polyneuropathy
Image
icon Presentation Type
Presentation
Image
location icon Location
Paris, France
Image
icon Title
FRENCH: HELIOS-A : Analyse randomisée de 18 mois d'extension du vutrisiran chez des patients atteints d'amylose héréditaire à transthyrétine avec polyneuropathie